Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1604157

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1604157

Global Ambulatory Polysomnography (PSG) System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3920
PDF (10-user License)
USD 4730
PDF (Corporate User License)
USD 7430

Add to Cart

The global demand for Ambulatory Polysomnography (PSG) System Market is presumed to reach the market size of nearly USD 778.14 Million by 2032 from USD 470.87 Million in 2023 with a CAGR of 5.74% under the study period 2024-2032.

Ambulatory Polysomnography (PSG) is a diagnostic tool used in sleep medicine to monitor and evaluate various physiological parameters during sleep. It is a portable system that allows for the assessment of sleep patterns, breathing, brain activity, heart rate, muscle activity, and other physiological measurements relevant to sleep disorders. The system typically consists of several sensors and electrodes that are non-invasively attached to the patient's body. These sensors record and transmit data to a portable recording device worn by the patient, allowing for sleep monitoring outside of a traditional sleep laboratory or hospital setting.

MARKET DYNAMICS

The rising sleep disorders, such as sleep apnea and insomnia, have increased the demand for accurate diagnostic tools like ambulatory PSG systems. Technological advancements have made these systems more compact, portable, and user-friendly, offering improved convenience and comfort for patients. The shift towards home-based sleep testing has also fueled the market as it reduces costs and inconveniences associated with overnight stays in sleep laboratories. Increased awareness about the importance of healthy sleep and the consequences of untreated sleep disorders, along with screening programs, has contributed to the recognition of sleep disorders and increased demand for ambulatory PSG systems. The growing geriatric population, which is considered more susceptible to sleep disorders, has created a significant market for these systems. Additionally, improved reimbursement policies and insurance coverage have made ambulatory PSG systems more accessible to patients.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Ambulatory Polysomnography (PSG) System. The growth and trends of Ambulatory Polysomnography (PSG) System industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Ambulatory Polysomnography (PSG) System market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Up to 12 Channel
  • Up To 24 Channel
  • Up To 32 Channel
  • Above 32 Channel

By Application

  • Obstructive Sleep Apnea
  • Chronic Insomnia
  • Narcolepsy
  • Other

By End-use

  • Hospitals
  • Sleep Laboratories
  • Home Care Settings

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Ambulatory Polysomnography (PSG) System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ambulatory Polysomnography (PSG) System market include Koninklijke Philips N.V, Natus Medical Incorporated., Nihon Kohden Corporation, ResMed Inc., LoWenstein Medical Technology GmbH Co. KG., Neurosoft, Cadwell Industries Inc., Somnomedics Gmbh, Compumedics Ltd., Onera Technologies B.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112111442

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Up to 12 Channel Historic and Forecast Sales By Regions
  • 5.4. Up To 24 Channel Historic and Forecast Sales By Regions
  • 5.5. Up To 32 Channel Historic and Forecast Sales By Regions
  • 5.6. Above 32 Channel Historic and Forecast Sales By Regions

6. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Obstructive Sleep Apnea Historic and Forecast Sales By Regions
  • 6.4. Chronic Insomnia Historic and Forecast Sales By Regions
  • 6.5. Narcolepsy Historic and Forecast Sales By Regions
  • 6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Sleep Laboratories Historic and Forecast Sales By Regions
  • 7.5. Home Care Settings Historic and Forecast Sales By Regions

8. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM COMPANIES

  • 9.1. Ambulatory Polysomnography (PSG) System Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Koninklijke Philips N.V
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Natus Medical Incorporated.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Nihon Kohden Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. ResMed Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. LoWenstein Medical Technology GmbH Co. KG.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Neurosoft
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Cadwell Industries Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Somnomedics Gmbh
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Compumedics Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Onera Technologies B.V
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

Product Code: VMR112111442

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Up to 12 Channel Market Sales By Geography (USD MN)
  • Up To 24 Channel Market Sales By Geography (USD MN)
  • Up To 32 Channel Market Sales By Geography (USD MN)
  • Above 32 Channel Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Obstructive Sleep Apnea Market Sales By Geography (USD MN)
  • Chronic Insomnia Market Sales By Geography (USD MN)
  • Narcolepsy Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Sleep Laboratories Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Global Ambulatory Polysomnography (PSG) System Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Ambulatory Polysomnography (PSG) System Report
  • Market Research Process
  • Market Research Methodology
  • Global Ambulatory Polysomnography (PSG) System Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Up to 12 Channel Market Sales By Geography (USD MN)
  • Up To 24 Channel Market Sales By Geography (USD MN)
  • Up To 32 Channel Market Sales By Geography (USD MN)
  • Above 32 Channel Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Obstructive Sleep Apnea Market Sales By Geography (USD MN)
  • Chronic Insomnia Market Sales By Geography (USD MN)
  • Narcolepsy Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Sleep Laboratories Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!